GPRIN1 enhances gallbladder cancer progression and is associated with the CDK1 pathway
- 1Department of General Surgery & Biliary Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
- 2Shanghai Engineering Research Center of Biliary Tract Minimal Invasive Surgery and Materials, Shanghai, China
- 3Biliary Tract Disease Institute, Fudan University, Shanghai, China
Abstract
G protein-regulated inducer of neurite outgrowth 1 (GPRIN1), a predominantly membrane-bound protein highly enriched in neurite growth cones and neurite outgrowth, plays a crucial role in neuronal network development. Recent studies have also shown that GPRIN1 participates in regulating cancer proliferation and migration. However, there is limited research regarding its role in gallbladder cancer (GBC). In this study, we found that GPRIN1 expression was upregulated in GBC tissues (p < 0.01) compared to normal tissues, and high GPRIN1 expression was positively correlated with poor prognosis (p < 0.001) in GBC patients. Both in vitro and in vivo studies showed that high GPRIN1 expression reinforced the proliferative and invasive capacities of GBC. Coimmunoprecipitation assays and mass spectrometry were performed to identify GPRIN1-interacting proteins. Biosynthesis analysis and Western blot further validated that there was a direct interaction between GPRIN1 and cyclin-dependent protein kinase 1 (CDK1). Then, cell proliferation, MTT and Transwell assays were performed to verify the functional recovery effect of CDK1 on GPRIN1. Moreover, we performed proteomic analysis of differentially expressed proteins and phosphorylated peptides separately, and a combined analysis was subsequently performed, which revealed the involvement of CDK1 in many biological processes and cellular pathways. Collectively, GPRIN1 enhances GBC cell invasion and metastasis, potentially through activation of the CDK1 pathway.
Related
- JARID2 promotes prostate cancer progression associated with TET3-mediated activation of the FAK/PI3K/AKT signaling pathway
- TP53 mutation promotes sunitinib resistance in gallbladder cancer via the ARHGEF7-AS2/miR-326/AXL pathway
- DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
- AMOT mediates YAP1 activation and promotes the cell progression and glycolysis in non-small cell lung cancer by modulating the Hippo signaling pathway
- FBXO17 regulates the malignant progression of colorectal cancer via the Wnt/β-catenin pathway
BibTeX
@article{li2026gprin1,
title = {{GPRIN1 enhances gallbladder cancer progression and is associated with the CDK1 pathway}},
author = {Min Li and Xiaojian Ni and Zijun Gong and Lujun Song and Tao Suo and Han Liu and Sheng Shen and Houbao Liu and Xiaoling Ni},
journal = {Cancer Biology \& Therapy},
year = {2026},
month = nov,
doi = {10.1080/15384047.2026.2753819},
url = {https://doi.org/10.1080/15384047.2026.2753819},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - GPRIN1 enhances gallbladder cancer progression and is associated with the CDK1 pathway
AU - Min Li
AU - Xiaojian Ni
AU - Zijun Gong
AU - Lujun Song
AU - Tao Suo
AU - Han Liu
AU - Sheng Shen
AU - Houbao Liu
AU - Xiaoling Ni
PY - 2026
DA - 2026/11/05
JO - Cancer Biology & Therapy
DO - 10.1080/15384047.2026.2753819
UR - https://doi.org/10.1080/15384047.2026.2753819
AB - G protein-regulated inducer of neurite outgrowth 1 (GPRIN1), a predominantly membrane-bound protein highly enriched in neurite growth cones and neurite outgrowth, plays a crucial role in neuronal network development. Recent studies have also shown that GPRIN1 participates in regulating cancer proliferation and migration. However, there is limited research regarding its role in gallbladder cancer (GBC). In this study, we found that GPRIN1 expression was upregulated in GBC tissues (p < 0.01) compared to normal tissues, and high GPRIN1 expression was positively correlated with poor prognosis (p < 0.001) in GBC patients. Both in vitro and in vivo studies showed that high GPRIN1 expression reinforced the proliferative and invasive capacities of GBC. Coimmunoprecipitation assays and mass spectrometry were performed to identify GPRIN1-interacting proteins. Biosynthesis analysis and Western blot further validated that there was a direct interaction between GPRIN1 and cyclin-dependent protein kinase 1 (CDK1). Then, cell proliferation, MTT and Transwell assays were performed to verify the functional recovery effect of CDK1 on GPRIN1. Moreover, we performed proteomic analysis of differentially expressed proteins and phosphorylated peptides separately, and a combined analysis was subsequently performed, which revealed the involvement of CDK1 in many biological processes and cellular pathways. Collectively, GPRIN1 enhances GBC cell invasion and metastasis, potentially through activation of the CDK1 pathway.
SN - 1538-4047
SN - 1555-8576
ER -